Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
What We Still Need to Learn We need more studies designed specifically for menopausal women rather than general adult populations, research on combination therapies (including HT plus GLP-1s, where the early data is promising but still small and largely retrospective), longer-term data on resistance training protocols for menopausal women, and research on how menopause-related body changes intersect with the other conditions common in this transition
In 2013, Phongmitr et al
This discrepancy suggests that the conventional view that LCACs are generally harmful may not be universally applicable to all types of LCACs
In the OASIS 4 clinical trial, patients taking the oral pill lost about 13.6-16.6% of body weight over 64 weeks, while the STEP 1 trial showed around 14.9% weight loss with the weekly injection
Lancet 387 (10015), 251272
US$ 20.10
US$ 21.56
US$ 21.85
US$ 29.05
US$ 27.63
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
